Location History:
- Merelbeke, BE (2012)
- Zomergem, BE (2007 - 2017)
Company Filing History:
8 out of 489 
1 out of 104 
1 out of 832,880 Years Active: 2007-2017
Title: The Innovative Contributions of Inventor Hans Nauwynck
Introduction: Hans Nauwynck, a prominent inventor based in Zomergem, Belgium, has made significant strides in the field of virology. With a remarkable portfolio of nine patents, he has focused on developing methods and technologies that enhance our understanding and treatment of viral infections. His work is pivotal, particularly concerning vaccines and the antigenicity of viruses.
Latest Patents: Among his latest inventions, Nauwynck has developed a method for the **Determination of Antigenicity of an Inactivated Virus**. This invention relates to virology, providing methods for assessing the impacts of viral inactivation procedures on viruses from families such as Arteriviridae, Coronaviridae, and Asfarviridae, with a keen focus on the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). Furthermore, he has introduced techniques for screening anti-viral compounds and methods for using the resulting inactivated and immunogenic viruses in vaccine production.
Another notable patent involves **Culturing Circular ssDNA Viruses for the Production of Vaccines**. This innovation includes using interferon in the in vitro cultivation of animal circular ssDNA viruses, such as Porcine Circovirus 2 or human TT virus. His approach demonstrates increased virus titres through the addition of interferons and agents that stimulate endogenous interferon production, showcasing his commitment to advancing vaccine development.
Career Highlights: Nauwynck's career includes significant contributions while working at prestigious institutions like Universiteit Gent. Here, he has honed his skills and expanded his research capabilities, leading to his current innovations in the field of virology and vaccine production.
Collaborations: Throughout his journey, Nauwynck has collaborated with esteemed professionals such as Peter Delputte and Gerald Misinzo. These partnerships have facilitated knowledge sharing and innovation, enhancing the impact of his inventions in the scientific community.
Conclusion: Hans Nauwynck embodies the spirit of innovation and dedication in the field of virology. His patents not only advance scientific understanding but also pave the way for effective vaccines and antiviral treatments. As he continues to push the boundaries of his research, the implications of his work are sure to resonate within the medical and scientific communities for years to come.